Zeria Pharmaceutical Co., Ltd. (4559.T)
JPY 2325.0
(-0.73%)
JPY 2325.0
(-0.73%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 7.73 Billion JPY | 24.78% |
| 2022 | 6.19 Billion JPY | 56.41% |
| 2021 | 3.96 Billion JPY | 26.03% |
| 2020 | 3.14 Billion JPY | 7.44% |
| 2019 | 2.92 Billion JPY | -15.31% |
| 2018 | 3.45 Billion JPY | -16.93% |
| 2017 | 4.15 Billion JPY | 17.31% |
| 2016 | 3.54 Billion JPY | 0.88% |
| 2015 | 3.51 Billion JPY | 37.37% |
| 2014 | 2.55 Billion JPY | -51.53% |
| 2013 | 5.27 Billion JPY | 32.52% |
| 2012 | 3.98 Billion JPY | 39.19% |
| 2011 | 2.86 Billion JPY | 55.26% |
| 2010 | 1.84 Billion JPY | 83.94% |
| 2009 | 1 Billion JPY | -16.74% |
| 2008 | 1.2 Billion JPY | -26.6% |
| 2007 | 1.63 Billion JPY | -20.75% |
| 2006 | 2.06 Billion JPY | 65.62% |
| 2005 | 1.24 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 4.21 Billion JPY | 708.61% |
| 2023 Q1 | 2.91 Billion JPY | 1255.87% |
| 2023 FY | 7.73 Billion JPY | 24.78% |
| 2023 Q3 | 3.02 Billion JPY | 21.97% |
| 2023 Q2 | 2.48 Billion JPY | -14.89% |
| 2023 Q4 | -692.07 Million JPY | -122.87% |
| 2022 Q3 | 1.98 Billion JPY | 41.86% |
| 2022 Q1 | 2.6 Billion JPY | 3256.71% |
| 2022 FY | 6.19 Billion JPY | 56.41% |
| 2022 Q4 | 215.02 Million JPY | -89.15% |
| 2022 Q2 | 1.39 Billion JPY | -46.28% |
| 2021 Q3 | 1.92 Billion JPY | 172.63% |
| 2021 FY | 3.96 Billion JPY | 26.03% |
| 2021 Q1 | 1.4 Billion JPY | 348.74% |
| 2021 Q2 | 707.03 Million JPY | -49.82% |
| 2021 Q4 | -82.4 Million JPY | -104.28% |
| 2020 Q3 | 2.29 Billion JPY | 454.37% |
| 2020 FY | 3.14 Billion JPY | 7.44% |
| 2020 Q1 | 974.16 Million JPY | 66.39% |
| 2020 Q4 | -566.43 Million JPY | -124.65% |
| 2020 Q2 | 414.45 Million JPY | -57.46% |
| 2019 Q4 | 585.46 Million JPY | -47.23% |
| 2019 Q3 | 1.1 Billion JPY | 1219.29% |
| 2019 Q2 | 84.1 Million JPY | -92.66% |
| 2019 FY | 2.92 Billion JPY | -15.31% |
| 2019 Q1 | 1.14 Billion JPY | 107.24% |
| 2018 FY | 3.45 Billion JPY | -16.93% |
| 2018 Q4 | 553.1 Million JPY | -10.86% |
| 2018 Q3 | 620.46 Million JPY | 1615.71% |
| 2018 Q2 | 36.16 Million JPY | -98.39% |
| 2018 Q1 | 2.24 Billion JPY | 1007.23% |
| 2017 Q4 | 202.7 Million JPY | -88.9% |
| 2017 FY | 4.15 Billion JPY | 17.31% |
| 2017 Q3 | 1.82 Billion JPY | 24.21% |
| 2017 Q2 | 1.47 Billion JPY | 123.65% |
| 2017 Q1 | 657.59 Million JPY | -1.95% |
| 2016 Q2 | 678.34 Million JPY | -48.94% |
| 2016 Q1 | 1.32 Billion JPY | 645.16% |
| 2016 Q4 | 670.65 Million JPY | -22.63% |
| 2016 Q3 | 866.86 Million JPY | 27.79% |
| 2016 FY | 3.54 Billion JPY | 0.88% |
| 2015 Q3 | 1.71 Billion JPY | 137.04% |
| 2015 Q1 | 891.89 Million JPY | 248.03% |
| 2015 FY | 3.51 Billion JPY | 37.37% |
| 2015 Q4 | 178.28 Million JPY | -89.62% |
| 2015 Q2 | 724.92 Million JPY | -18.72% |
| 2014 FY | 2.55 Billion JPY | -51.53% |
| 2014 Q3 | 1.04 Billion JPY | -2.11% |
| 2014 Q2 | 1.06 Billion JPY | 1.74% |
| 2014 Q1 | 1.04 Billion JPY | 48.54% |
| 2014 Q4 | -602.51 Million JPY | -157.69% |
| 2013 FY | 5.27 Billion JPY | 32.52% |
| 2013 Q4 | 705.99 Million JPY | -42.82% |
| 2013 Q3 | 1.23 Billion JPY | 37.05% |
| 2013 Q2 | 900.86 Million JPY | -63.01% |
| 2013 Q1 | 2.43 Billion JPY | 245.75% |
| 2012 Q3 | 1.05 Billion JPY | -20.34% |
| 2012 Q4 | 704.44 Million JPY | -33.48% |
| 2012 Q2 | 1.32 Billion JPY | 49.44% |
| 2012 FY | 3.98 Billion JPY | 39.19% |
| 2012 Q1 | 889.54 Million JPY | 1436.74% |
| 2011 Q1 | 1.03 Billion JPY | 837.23% |
| 2011 FY | 2.86 Billion JPY | 55.26% |
| 2011 Q2 | 720.29 Million JPY | -30.08% |
| 2011 Q3 | 1.17 Billion JPY | 63.42% |
| 2011 Q4 | -66.54 Million JPY | -105.65% |
| 2010 Q1 | 209.84 Million JPY | -15.75% |
| 2010 Q4 | 109.91 Million JPY | -79.72% |
| 2010 Q2 | 981.02 Million JPY | 367.5% |
| 2010 FY | 1.84 Billion JPY | 83.94% |
| 2010 Q3 | 541.9 Million JPY | -44.76% |
| 2009 Q4 | 249.08 Million JPY | 42.96% |
| 2009 Q3 | 174.24 Million JPY | -56.57% |
| 2009 Q2 | 401.22 Million JPY | 126.41% |
| 2009 Q1 | 177.21 Million JPY | -47.42% |
| 2009 FY | 1 Billion JPY | -16.74% |
| 2008 Q2 | 552.08 Million JPY | 0.0% |
| 2008 Q3 | 93.79 Million JPY | -83.01% |
| 2008 FY | 1.2 Billion JPY | -26.6% |
| 2008 Q4 | 337.04 Million JPY | 259.33% |
| 2007 FY | 1.63 Billion JPY | -20.75% |
| 2006 FY | 2.06 Billion JPY | 65.62% |
| 2005 FY | 1.24 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -141.225% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 94.634% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 102.455% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 95.228% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -6995.57% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 70.093% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | 3.66% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 81.769% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -1009.22% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 44.654% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -70.03% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -461.457% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 4395.146% |
| Tsumura & Co. | 16.7 Billion JPY | 53.724% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 30.723% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -87.698% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 52.196% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -125.073% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -45.27% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 257.974% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -134.636% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 493.886% |
| MedRx Co., Ltd | -932 Million JPY | 929.535% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -104.843% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 795.257% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 423.237% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -2.469% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 43.547% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 1412.138% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 62.573% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -162.403% |